Search results for "Risk reduction behavior"

showing 8 items of 58 documents

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology …

2019

Aims The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5…

cardiovascular risk factorsMaleCardiac & Cardiovascular SystemsHeart diseaseEpidemiologymedicine.medical_treatmentHealth StatusEUROASPIRE ; cardiovascular risk factors ; guidelines ; lifestyle ; secondary preventionRisk Reduction Behavior*HSM CARRisk FactorsSecondary PreventionARTERY-DISEASEMyocardial infarctionEUROASPIREguidelinesDiet / adverse effectsRegistriesCardiovascular Diseases / physiopathology1102 Cardiorespiratory Medicine and HaematologyHydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*Smoking / epidemiologySmokingHealthy Lifestyle*Middle AgedPREVALENCEEuropeCardiovascular Diseases / diagnosisTreatment OutcomeCardiovascular DiseasesCardiovascular Agents / therapeutic use*LDL Cholesterol LipoproteinsFemaleEurope / epidemiologyCardiology and Cardiovascular MedicineLife Sciences & Biomedicinesecondary preventionmedicine.medical_specialtylifestyleSmoking / adverse effectsCardiovascular risk factorsHEART-DISEASERisk AssessmentLOW-INCOME COUNTRIESLife Style*Cardiovascular Diseases / prevention & control*Cardiovascular preventionmedicineJournal ArticleHumansHealthy Lifestyleddc:610Risk factorLife StyleAgedCardiovascular Diseases / epidemiologyScience & TechnologyTask forcebusiness.industryCardiovascular AgentsSMOKING-CESSATIONProtective Factorsmedicine.diseaseDietEUROASPIRE Investigators*Cross-Sectional StudiesMYOCARDIAL-INFARCTIONCLINICAL-PRACTICEFamily medicineHealth Care SurveysCardiovascular System & CardiologySmoking cessationPatient ComplianceHydroxymethylglutaryl-CoA Reductase InhibitorsSedentary BehaviorbusinessRisk Reduction BehaviorTASK-FORCE
researchProduct

Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study.

2018

Background Previous evidence indicates that sauna bathing is related to a reduced risk of fatal cardiovascular disease (CVD) events in men. The aim of this study was to investigate the relationship between sauna habits and CVD mortality in men and women, and whether adding information on sauna habits to conventional cardiovascular risk factors is associated with improvement in prediction of CVD mortality risk. Methods Sauna bathing habits were assessed at baseline in a sample of 1688 participants (mean age 63; range 53–74 years), of whom 51.4% were women. Multivariable-adjusted hazard ratios (HRs) were calculated to investigate the relationships of frequency and duration of sauna use with C…

kuolleisuusMalesaunominenPreventionlcsh:Rehkäisylcsh:MedicineGenderMiddle AgedCardiovascular diseaseSauna bathingRisk predictionsukupuoliSteam BathCardiovascular DiseasesRisk Factorssydän- ja verisuonitauditHumansennaltaehkäisyFemaleProspective StudiesRisk Reduction BehaviorResearch ArticleAgedProportional Hazards Models
researchProduct

Is sauna bathing protective of sudden cardiac death? A review of the evidence

2019

Sudden cardiac death (SCD) is a global public health burden accounting for 15–20% of all deaths. Though established atherosclerotic risk factors explain a large proportion of the risk of SCD, these factors are often absent in a large proportion of SCD victims and the pathogenesis of SCD is still not fully established. It therefore appears that additional factors may be involved. Sauna bathing is a traditional Finnish activity that is mainly used for the purposes of relaxation and pleasure. Beyond its use for these purposes, sauna bathing has been linked with several health benefits. Emerging evidence suggests that sauna bathing is associated with reduced risk of adverse cardiovascular (CV) …

medicine.medical_specialtyDisease030204 cardiovascular system & hematologysudden cardiac deathSteam Bathlaw.inventionSudden cardiac deathCardiovascular Physiological Phenomena03 medical and health sciencesSauna bathing0302 clinical medicineRandomized controlled trialRisk FactorslawHumansMedicine030212 general & internal medicineIntensive care medicinebusiness.industryFinnish sauna bathingPublic healthArrhythmias Cardiacmedicine.diseaseDeath Sudden CardiacArterial stiffnessObservational studyGeneral healthCardiology and Cardiovascular MedicinebusinessRisk Reduction BehaviorProgress in Cardiovascular Diseases
researchProduct

The diabetogenic action of statins — mechanisms and clinical implications

2015

Treatment with statins has transformed primary and secondary prevention of cardiovascular disease (CVD), including thrombotic stroke. Evidence-based data demonstrate the benefits and safety of statin therapy and help to guide clinicians in the management of populations at high risk of CVD. Nevertheless, clinical trials, meta-analyses and observational studies highlight a 10-12% increase in new-onset diabetes mellitus (NODM) among patients receiving statins. The risk further increases with intensive therapy and among individuals with known risk factors for NODM. Mechanisms underpinning this effect are not yet fully understood; however, Mendelian randomization studies suggest that they are re…

medicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismDiseaseType 2 diabetesIn Vitro Techniques030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistancePharmacotherapyRisk FactorsInsulin-Secreting CellsDiabetes mellitusMendelian randomizationSecondary PreventionAnimalsHumansMedicinecardiovascular diseasesIntensive care medicinebusiness.industrynutritional and metabolic diseasesFeeding BehaviorMendelian Randomization Analysismedicine.diseaseClinical trialDiabetes Mellitus Type 2Cardiovascular DiseasesPhysical therapyHydroxymethylglutaryl CoA ReductasesObservational studyHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistancebusinessRisk Reduction BehaviorNature Reviews Endocrinology
researchProduct

The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial.

2013

Summary Background & aims Metabolic syndrome (MetS), in which a non-classic feature is an increase in systemic oxidative biomarkers, presents a high risk of diabetes and cardiovascular disease (CVD). Adherence to the Mediterranean Diet (MedDiet) is associated with a reduced risk of MetS. However, the effect of the MedDiet on biomarkers for oxidative damage has not been assessed in MetS individuals. We have investigated the effect of the MedDiet on systemic oxidative biomarkers in MetS individuals. Methods Randomized, controlled, parallel clinical trial in which 110 female with MetS, aged 55–80, were recruited into a large trial (PREDIMED Study) to test the efficacy of the traditional MedDie…

medicine.medical_specialtyMediterranean dietUrinary systemCritical Care and Intensive Care Medicinemedicine.disease_causeDiet Mediterraneanlaw.inventionRandomized controlled triallawRisk FactorsInternal medicineDiabetes mellitusmedicineHumansNutsPlant OilsDiet Fat-RestrictedOlive OilAgedAged 80 and overMetabolic SyndromeF2-IsoprostanesNutrition and Dieteticsbusiness.industryDeoxyguanosineMiddle Agedmedicine.diseaseLipid MetabolismClinical trialOxidative StressEndocrinology8-Hydroxy-2'-DeoxyguanosineCardiovascular DiseasesFemaleMetabolic syndromebusinessBody mass indexRisk Reduction BehaviorOxidative stressBiomarkersDNA DamageClinical nutrition (Edinburgh, Scotland)
researchProduct

Link of the mechanisms of action of glatiramer acetate to its long-term clinical data

2009

A consequence of the long-term nature of progression in multiple sclerosis is that treatment needs to be provided over the long term. Gathering evidence for long term clinical efficacy, safety and patient acceptance of immunomodulatory therapies is thus a critically important issue. However, pivotal trials, which generally last no more than two years, cannot address this issue. Glatiramer acetate is the only immunomodulatory treatment for which prospective data is available covering a treatment period of over a decade. In the long-term extension of the pivotal trial of glatiramer acetate, 108 patients have been followed for a mean treatment duration of 10.1 years. At the end of the treatmen…

medicine.medical_specialtyMultiple SclerosisTimeSecondary PreventionHumansMedicineClinical efficacyGlatiramer acetateIntensive care medicineClinical Trials as Topicbusiness.industryMultiple sclerosisGlatiramer AcetatePrognosismedicine.diseaseTreatment periodTerm (time)Clinical trialTreatment OutcomeNeurologyAmbulatoryDisease ProgressionPhysical therapyObservational studyNeurology (clinical)PeptidesbusinessRisk Reduction BehaviorImmunosuppressive Agentsmedicine.drugJournal of the Neurological Sciences
researchProduct

The metabolic syndrome in hypertension: European society of hypertension position statement.

2008

The metabolic syndrome considerably increases the risk of cardiovascular and renal events in hypertension. It has been associated with a wide range of classical and new cardiovascular risk factors as well as with early signs of subclinical cardiovascular and renal damage. Obesity and insulin resistance, beside a constellation of independent factors, which include molecules of hepatic, vascular, and immunologic origin with proinflammatory properties, have been implicated in the pathogenesis. The close relationships among the different components of the syndrome and their associated disturbances make it difficult to understand what the underlying causes and consequences are. At each of these …

medicine.medical_specialtyPhysiologySodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsPhysical exerciseAngiotensin-Converting Enzyme InhibitorsType 2 diabetesBioinformaticsInsulin resistanceWeight lossInternal medicineInternal MedicinemedicineHumansThiazideAntihypertensive AgentsMetabolic Syndromebusiness.industrymedicine.diseaseCalcium Channel BlockersObesityExercise TherapyEndocrinologyBlood pressureHypertensionmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor BlockersRisk Reduction Behaviormedicine.drugDiet TherapyJournal of hypertension
researchProduct

Heart failure risk reduction : is fit and overweight or obese better than unfit and normal weight?

2019

This article refers to ‘Cardiorespiratory fitness, body mass index and heart failure incidence’ by P. Kokkinos et al., published in this issue on pages 436–444.

medicine.medical_specialtymedicine.medical_treatmentheart failureHeart failureOverweightBody Mass IndexInternal medicinemedicineHumansoverweightObesityCardiorespiratory fitnesssydäntauditReduction (orthopedic surgery)business.industryIncidence (epidemiology)IncidenceCardiorespiratory fitnessylipainota3142ta3121medicine.diseaseObesityfitnessfyysinen kuntoNormal weightCardiorespiratory FitnessHeart failureCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexRisk Reduction BehaviorEuropean Journal of Heart Failure
researchProduct